Biomedical subjects
A S WIENER
Publications and source records attributed to A S WIENER.
History of the Rhesus blood types.
Explore the source record for details and available documents.
The mosaic structure of red blood cell agglutinogens.
Explore the source record for details and available documents.
A new rare Rhesus agglutinogen.
Explore the source record for details and available documents.
[Hemolytic anemia in a newborn].
Explore the source record for details and available documents.
Results of exchange transfusion in erythroblastosis fetalis.
Explore the source record for details and available documents.
Heredity of the M-N-S blood types; theoretico-statistical considerations.
Explore the source record for details and available documents.
Problems in the management of erythroblastosis fetalis, with five examples exhibiting unusual serological findings.
Explore the source record for details and available documents.
Blood-group factors and physiological icterus.
Explore the source record for details and available documents.
Intra-arterial transfusion.
Explore the source record for details and available documents.
Aetiology of physiological jaundice of the newborn.
Explore the source record for details and available documents.
The half-life of passively acquired antibody globulin molecules in infants.
By following the titer of passively acquired Rh antibodies in newborn infants, it is calculated that the half-life of the placenta-passing Rh antibody molecule is approximately 30 days. Evidence is offered that this estimate applies not only to placenta-passing Rh antibodies, but also to other placenta-passing antibodies, and not improbably to serum gamma globulin molecules in general. Studies on the fate of free Rh antibodies in erythroblastotic babies show that these antibodies often are eliminated no more rapidly in Rh-positive babies than in Rh-negative babies. On the other hand, incompatible alpha and beta antibodies, as a rule, are quickly neutralized and eliminated from the body of newborn infants. These observations provide one explanation for the lower incidence of erythroblastosis due to A-B sensitization in comparison with cases resulting from Rh sensitization.
The Rh-Hr blood types: serology, genetics, and nomenclature.
Explore the source record for details and available documents.
The management of the isosensitized pregnant patient and her erythroblastotic infant.
Explore the source record for details and available documents.
Studies on the use of enzyme-treated red cells in tests for Rh sensitization.
Explore the source record for details and available documents.
Origin of naturally occurring hemagglutinins and hemolysins; a review.
Explore the source record for details and available documents.
[Heredity and nomenclature of Rh-Hr blood groups].
Explore the source record for details and available documents.
[Blood group distribution in New York City, with special reference to rare agglutinogens].
Explore the source record for details and available documents.